Fudan and Zhangjiang voluntarily disclosed an announcement on the completion of the US Phase II clinical trial of injectable hempofen to treat erythematous moles

SZSI · Sep 24

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.